Evidence map›Paper›PMID 25386357›Full record

ArticleRambam Maimonides medical journal2014

Implementing thrombosis guidelines in cancer patients: a review.

Dominique Farge-Bancel, Henri Bounameaux, Benjamin Brenner, Harry R Büller, Ajay Kakkar, Ingrid Pabinger, Michael Streiff, Philippe Debourdeau

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Rambam Maimonides medical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Implementation failure: thromboprophylaxis in ambulatory patients with cancer.Hematology. American Society of Hematology. Education Program · 2025
    Review
  3. Review
  4. Article
  5. Deep Vein Thrombosis in Upper Limb in a Weightlifter.Open access Macedonian journal of medical sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dominique Farge-BancelAssistance Publique-Hôpitaux de Paris, Internal Medicine and Vascular Disease Unit, Saint-Louis Hospital; Sorbonne Paris Cité, Paris 7 Diderot University, Paris, France;
Henri BounameauxDivision of Angiology and Hemostasis, University Hospitals of Geneva and Faculty of Medicine, Geneva, Switzerland;
Benjamin BrennerDepartment of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel;
Harry R BüllerDepartment of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands;
Ajay KakkarThrombosis Research Institute and Queen Mary University of London, London, UK;
Ingrid PabingerDivision of Hematology and Hemostaseology, Department of Internal Medicine, Medical University Vienna, Vienna, Austria;
Michael StreiffDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Philippe DebourdeauInstitut Sainte Catherine, Avignon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as the need for adequate prevention and treatment. Management of venous thromboembolism in patients with cancer requires the coordinated efforts of a wide range of clinicians, highlighting the importance of a multidisciplinary approach. However, a lack of consensus among various national and international clinical practice guidelines has contributed to knowledge and practice gaps among practitioners, and inconsistent approaches to venous thromboembolism. The 2013 international guidelines for thrombosis in cancer have sought to address these gaps by critically re-evaluating the evidence coming from clinical trials and synthesizing a number of guidelines documents. An individualized approach to prophylaxis is recommended for all patients.

Indexed as

Anticoagulantscancerguidelinesthrombosisvenous thromboembolism

Identifiers

PMID25386357
PMCPMC4222430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.